Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Suisse (CSUI) EBIT Margin (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed EBIT Margin for 8 consecutive years, with 890.51% as the latest value for Q1 2025.

  • On a quarterly basis, EBIT Margin fell 5236.0% to 890.51% in Q1 2025 year-over-year; TTM through Nov 2025 was 3738.4%, a 269585.0% decrease, with the full-year FY2025 number at 1280.06%, down 42360.0% from a year prior.
  • EBIT Margin was 890.51% for Q1 2025 at Cannabis Suisse, up from 1230.79% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 532.19% in Q4 2021 to a low of 6242.08% in Q1 2023.
  • A 4-year average of 1416.03% and a median of 865.76% in 2023 define the central range for EBIT Margin.
  • Peak YoY movement for EBIT Margin: tumbled -136476bps in 2021, then surged 540393bps in 2024.
  • Cannabis Suisse's EBIT Margin stood at 532.19% in 2021, then decreased by -27bps to 676.03% in 2023, then tumbled by -82bps to 1230.79% in 2024, then grew by 28bps to 890.51% in 2025.
  • Per Business Quant, the three most recent readings for CSUI's EBIT Margin are 890.51% (Q1 2025), 1230.79% (Q4 2024), and 997.85% (Q3 2024).